PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Disease

Recurrence

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · OBSERVATIONAL STUDY

Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

ClinicalTrials.gov

This is a registry record for an ongoing observational study with no results posted; recruitment is active and no efficacy or safety data are yet reported.

PreliminaryHER2 Negative Breast Cancer SKB264 Monotherapy or Combination Therapy Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Reported

Planned enrollment500

Primary outcome measureTime to next treatment (TTNT) of SKB264 mon…

Study cohortsTriple-negative breast cancer (TNBC) and ho…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support